Abstract:Herein, this work reports the first synthetic vaccine adjuvants that attenuate potency in response to small, 1-2 °C changes in temperature about their lower critical solution temperature (LCST). Adjuvant additives significantly increase vaccine efficacy. However, adjuvants also cause inflammatory side effects, such as pyrexia, which currently limits their use. To address this, a thermophobic vaccine adjuvant engineered to attenuate potency at temperatures correlating to pyrexia is created. Thermophobic adjuvants are synthesized by combining a rationally designed trehalose glycolipid vaccine adjuvant with thermoresponsive poly-N-isoporpylacrylamide (NIPAM) via reversible addition fragmentation chain transfer (RAFT) polymerization. The resulting thermophobic adjuvants exhibit LCSTs near 37 °C, and self-assembled into nanoparticles with temperature-dependent sizes (90-270 nm). Thermophobic adjuvants activate HEK-mMINCLE and other innate immune cell lines as well as primary mouse bone marrow derived dendritic cells (BMDCs) and bone marrow derived macrophages (BMDMs). Inflammatory cytokine production is attenuated under conditions mimicking pyrexia (above the LCST) relative to homeostasis (37 °C) or below the LCST. This thermophobic behavior correlated with decreased adjuvant Rg is observed by DLS, as well as glycolipid-NIPAM shielding interactions are observed by NOESY-NMR. In vivo, thermophobic adjuvants enhance efficacy of a whole inactivated influenza A/California/04/2009 virus vaccine, by increasing neutralizing antibody titers and CD4+ /44+ /62L+ lung and lymph node central memory T cells, as well as providing better protection from morbidity after viral challenge relative to unadjuvanted control vaccine. Together, these results demonstrate the first adjuvants with potency regulated by temperature. This work envisions that with further investigation, this approach can enhance vaccine efficacy while maintaining safety.

Rational Design of Thermostable Vaccines by Engineered Peptide-Induced Virus Self-Biomineralization under Physiological Conditions

Genetic engineering heat stable vaccine and preparation method thereof

A Self-Assembling Nanoparticle: Implications for the Development of Thermostable Vaccine Candidates.

Conformation-Stabilized Amorphous Nanocoating for Rational Design of Long-Term Thermostable Viral Vaccines

Four Simple Biomimetic Mineralization Methods to Improve the Thermostability and Immunogenicity of Virus-like Particles as a Vaccine against Foot-and-Mouth Disease

Biomineralization Improves the Thermostability of Foot-and-mouth Disease Virus-Like Particles and the Protective Immune Response Induced

Robust Vaccine Formulation Produced by Assembling a Hybrid Coating of Polyethyleneimine-Silica.

Hydrated silica exterior produced by biomimetic silicification confers viral vaccine heat-resistance.

Eggshell‐Inspired Biomineralization Generates Vaccines That Do Not Require Refrigeration

Clinical and Preclinical Methods of Heat-Stabilization of Human Vaccines

Biomineralized vaccine nanohybrid for needle-free intranasal immunization

Rational Design of a Replication‐Competent and Inheritable Magnetic Viruses for Targeting Biomedical Applications

Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation

Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71

A universal design of restructured dimer antigens: Development of a superior vaccine against the paramyxovirus in transgenic rice

Vaccine Engineering with Dual-Functional Mineral Shell: A Promising Strategy to Overcome Preexisting Immunity.

Thermophobic Trehalose Glycopolymers as Smart C-Type Lectin Receptor Vaccine Adjuvants

Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films

A promising strategy to improve the stability and immunogenicity of killed but metabolically active vaccines: low-temperature preparation and coating of nanoparticles

Stabilization of vaccines and antibiotics in silk and eliminating the cold chain

Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform